| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70839-300-30 | 70839-300 | HUMAN PRESCRIPTION DRUG | Tekturna | aliskiren hemifumarate | TABLET, FILM COATED | ORAL | 20170101 | N/A | NDA | NDA021985 | LXO US Inc. | ALISKIREN HEMIFUMARATE | 300 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (70839-300-30) |
| 70839-150-30 | 70839-150 | HUMAN PRESCRIPTION DRUG | Tekturna | aliskiren hemifumarate | TABLET, FILM COATED | ORAL | 20170101 | N/A | NDA | NDA021985 | LXO US Inc. | ALISKIREN HEMIFUMARATE | 150 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (70839-150-30) |
| 66993-142-30 | 66993-142 | HUMAN PRESCRIPTION DRUG | Aliskiren | aliskiren hemifumarate | TABLET, FILM COATED | ORAL | 20190304 | N/A | NDA AUTHORIZED GENERIC | NDA021985 | Prasco Laboratories | ALISKIREN HEMIFUMARATE | 300 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (66993-142-30) |
| 66993-141-30 | 66993-141 | HUMAN PRESCRIPTION DRUG | Aliskiren | aliskiren hemifumarate | TABLET, FILM COATED | ORAL | 20190304 | N/A | NDA AUTHORIZED GENERIC | NDA021985 | Prasco Laboratories | ALISKIREN HEMIFUMARATE | 150 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (66993-141-30) |